SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-129738
Filing Date
2021-10-26
Accepted
2021-10-26 07:00:59
Documents
15
Period of Report
2021-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130996d1_8k.htm   iXBRL 8-K 42372
2 EXHIBIT 2.1 tm2130996d1_ex2-1.htm EX-2.1 309737
3 EXHIBIT 10.1 tm2130996d1_ex10-1.htm EX-10.1 54554
4 EXHIBIT 99.1 tm2130996d1_ex99-1.htm EX-99.1 11178
  Complete submission text file 0001104659-21-129738.txt   677414

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20211021.xsd EX-101.SCH 3040
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20211021_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20211021_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2130996d1_8k_htm.xml XML 3611
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 211345899
SIC: 2834 Pharmaceutical Preparations